Interaction of Cowpea Mosaic Virus Nanoparticles with Surface Vimentin and Inflammatory Cells in Atherosclerotic Lesions

• Slevin M , BadimonL, Grau-OlivaresMet al. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Mol. Biosyst. 6(3), 444–450 (2010).
   PubMedGoogle Scholar
• Cybulsky MI , Jongstra-BilenJ. Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol.21(5), 397–403 (2010).
   PubMed Web of Science ®Google Scholar
• Tavora F , CresswellN, LiL, RippleM, BurkeA. Immunolocalisation of fibrin in coronary atherosclerosis: implications for necrotic core development. Pathology42(1), 15–22 (2010).
   PubMed Web of Science ®Google Scholar
• Ota H , YuW, UnderhillHRet al. Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler. Thromb. Vasc. Biol. 29(10), 1696–1701 (2009).
   PubMed Web of Science ®Google Scholar
• Ovchinnikova O , GylfeA, BaileyLet al. Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report. Arterioscler. Thromb. Vasc. Biol. 29(10), 1478–1480 (2009).
   PubMed Web of Science ®Google Scholar
• Van Den Diepstraten C , PapayK, BolenderZ, BrownA, PickeringJG. Cloning of a novel prolyl 4-hydroxylase subunit expressed in the fibrous cap of human atherosclerotic plaque. Circulation108(5), 508–511 (2003).
   PubMed Web of Science ®Google Scholar
• Heeneman S , CleutjensJP, FaberBCet al. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J. Pathol. 200(4), 516–525 (2003).
   PubMed Web of Science ®Google Scholar
• McNeill E , ChannonKM, GreavesDR. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin. Sci. (Lond.)118(11), 641–655 (2010).
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S , BentzonJF, DaemenMet al. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb. Haemost. 106(1), 1–19 (2011).
   PubMed Web of Science ®Google Scholar
• Ambrose JA . In search of the ‘vulnerable plaque‘: can it be localized and will focal regional therapy ever be an option for cardiac prevention? J. Am. Coll. Cardiol.51(16), 1539–1542 (2008).
   PubMed Web of Science ®Google Scholar
• Kubo T , ImanishiT, TakaradaSet al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J. Am. Coll. Cardiol. 50(10), 933–939 (2007).
   PubMed Web of Science ®Google Scholar
• Kolodgie FD , NarulaJ, YuanC, BurkeAP, FinnAV, VirmaniR. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J. Am. Coll. Cardiol.49(21), 2093–2101 (2007).
   PubMed Web of Science ®Google Scholar
• Carlier SG , De Korte CL, Brusseau E, Schaar JA, Serruys PW, Van Der Steen AF. Imaging of atherosclerosis. Elastography. J. Cardiovasc. Risk9(5), 237–245 (2002).
   PubMedGoogle Scholar
• Madjid M , NaghaviM, MalikBA, LitovskyS, WillersonJT, CasscellsW. Thermal detection of vulnerable plaque. Am. J. Cardiol.90(10C), 36L–39L (2002).
   PubMed Web of Science ®Google Scholar
• Demos SM , Alkan-OnyukselH, KaneBJet al.: In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J. Am. Coll. Cardiol.33(3), 867–875 (1999).
   PubMed Web of Science ®Google Scholar
• Unno N , MitsuokaH, TakeiYet al. Virtual angioscopy using 3-dimensional rotational digital subtraction angiography for endovascular assessment. J. Endovasc. Ther. 9(4), 529–534 (2002).
   PubMed Web of Science ®Google Scholar
• Libby P . Inflammation in atherosclerosis. Nature420(6917), 868–874 (2002).
   PubMed Web of Science ®Google Scholar
• Shimizu K , MitchellRN, LibbyP. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol.26(5), 987–994 (2006).
   PubMed Web of Science ®Google Scholar
• Nahrendorf M , JafferFA, KellyKAet al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114(14), 1504–1511 (2006).
   PubMed Web of Science ®Google Scholar
• Laitinen I , SarasteA, WeidlEet al. Evaluation of αvβ3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ. Cardiovasc. Imaging 2(4), 331–338 (2009).
   PubMed Web of Science ®Google Scholar
• Tawakol A , CastanoAP, GadFet al. Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. Photochem. Photobiol. Sci. 7(1), 33–39 (2008).
   PubMed Web of Science ®Google Scholar
• Cole JE , MitraAT, MonacoC. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets. Expert Rev. Cardiovasc. Ther.8(11), 1619–1635 (2010).
   PubMedGoogle Scholar
• Quillard T , CroceK, JafferFA, WeisslederR, LibbyP. Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo. Thromb. Haemost.105(5), 828–836 (2010).
   Web of Science ®Google Scholar
• Winter PM , MorawskiAM, CaruthersSDet al. Molecular imaging of angiogenesis in early-stage atherosclerosis with α(v)β3-integrin-targeted nanoparticles. Circulation 108(18), 2270–2274 (2003).
   PubMed Web of Science ®Google Scholar
• Kuroda S , MukohyamaH, KondoHet al. Bone mineral density of the mandible in ovariectomized rats: analyses using dual energy X-ray absorptiometry and peripheral quantitative computed tomography. Oral Dis. 9(1), 24–28 (2003).
   PubMed Web of Science ®Google Scholar
• Sajja HK , EastMP, MaoH, WangYA, NieS, YangL. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr. Drug Discov. Technol.6(1), 43–51 (2009).
   PubMedGoogle Scholar
• Cormode DP , SkajaaT, FayadZA, MulderWJ. Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol.29(7), 992–1000 (2009).
   PubMed Web of Science ®Google Scholar
• Allen M , BulteJW, LiepoldLet al. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn. Reson. Med. 54(4), 807–812 (2005).
   PubMed Web of Science ®Google Scholar
• Cormode DP , JarzynaPA, MulderWJ, FayadZA. Modified natural nanoparticles as contrast agents for medical imaging. Adv. Drug Deliv. Rev.62(3), 329–338 (2010).
   PubMed Web of Science ®Google Scholar
• Lewis JD , DestitoG, ZijlstraAet al. Viral nanoparticles as tools for intravital vascular imaging. Nat. Med. 12(3), 354–360 (2006).
   PubMed Web of Science ®Google Scholar
• Leong HS , SteinmetzNF, AblackAet al. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat. Protoc. 5(8), 1406–1417 (2010).
   PubMed Web of Science ®Google Scholar
• Koudelka KJ , DestitoG, PlummerEM, TraugerSA, SiuzdakG, ManchesterM. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog.5(5), e1000417 (2009).
   PubMed Web of Science ®Google Scholar
• Koudelka KJ , RaeCS, GonzalezMJ, ManchesterM. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus. J. Virol.81(4), 1632–1640 (2007).
   PubMed Web of Science ®Google Scholar
• Mor-Vaknin N , PunturieriA, SitwalaK, MarkovitzDM. Vimentin is secreted by activated macrophages. Nat. Cell Biol.5(1), 59–63 (2003).
   PubMed Web of Science ®Google Scholar
• Gonzalez MJ , PlummerEM, RaeCS, ManchesterM. Interaction of cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS ONE4(11), e7981 (2009).
   PubMed Web of Science ®Google Scholar
• Woollard KJ , GeissmannF. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol.7(2), 77–86 (2010).
   PubMed Web of Science ®Google Scholar
• Pamukcu B , LipGY, DevittA, GriffithsH, ShantsilaE. The role of monocytes in atherosclerotic coronary artery disease. Ann. Med.42(6), 394–403 (2010).
   PubMed Web of Science ®Google Scholar
• Lundberg AM , HanssonGK. Innate immune signals in atherosclerosis. Clin. Immunol.134(1), 5–24 (2010).
   PubMed Web of Science ®Google Scholar
• Webb NR , MooreKJ. Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy. Curr. Drug Targets8(12), 1249–1263 (2007).
   PubMed Web of Science ®Google Scholar
• Siegel-Axel D , DaubK, SeizerP, LindemannS, GawazM. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc. Res.78(1), 8–17 (2008).
   PubMed Web of Science ®Google Scholar
• Zaragoza C , Gomez-GuerreroC, Martin-VenturaJLet al. Animal models of cardiovascular diseases. J. Biomed. Biotechnol. 2011, 497841 (2011).
   PubMedGoogle Scholar
• Merkel M , Velez-CarrascoW, HudginsLC, BreslowJL. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc. Natl Acad. Sci. USA98(23), 13294–13299 (2001).
   PubMed Web of Science ®Google Scholar
• Babaev VR , PatelMB, SemenkovichCF, FazioS, LintonMF. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J. Biol. Chem.275(34), 26293–26299 (2000).
   PubMed Web of Science ®Google Scholar
• Jiang Z , GeorgelP, DuXet al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6(6), 565–570 (2005).
   PubMed Web of Science ®Google Scholar
• Rae CS , KhorIW, WangQet al. Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 343(2), 224–235 (2005).
   PubMed Web of Science ®Google Scholar
• Davignon J , GanzP. Role of endothelial dysfunction in atherosclerosis. Circulation109(23 Suppl. 1), III27–III32 (2004).
   PubMed Web of Science ®Google Scholar
• Eefting FD , PasterkampG, ClarijsRJ, Van Leeuwen TG, Borst C. Remodeling of the atherosclerotic arterial wall: a determinant of luminal narrowing in human coronary arteries. Coron. Artery Dis.8(7), 415–421 (1997).
   PubMed Web of Science ®Google Scholar
• Steinmetz NF , ChoCF, AblackA, LewisJD, ManchesterM. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomedicine (Lond).6(2), 351–364 (2011).
   PubMed Web of Science ®Google Scholar
• Nahrendorf M , ZhangH, HembradorSet al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117(3), 379–387 (2008).
   PubMed Web of Science ®Google Scholar
• Tearney GJ , YabushitaH, HouserSLet al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 107(1), 113–119 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang Z , MachacJ, HelftGet al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl. Med. 6, 3 (2006).
   PubMedGoogle Scholar
• Lipinski MJ , FriasJC, AmirbekianVet al. Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. JACC Cardiovasc. Imaging 2(5), 637–647 (2009).
   PubMed Web of Science ®Google Scholar
• Bryant AE , BayerCR, HuntingtonJD, StevensDL. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J. Infect. Dis.193(12), 1685–1692 (2006).
   PubMed Web of Science ®Google Scholar
• Garg A , BarnesPF, PorgadorAet al. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J. Immunol. 177(9), 6192–6198 (2006).
   PubMed Web of Science ®Google Scholar
• Huet D , BagotM, LoyauxDet al. SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J. Immunol. 176(1), 652–659 (2006).
   PubMed Web of Science ®Google Scholar
• Leong HS , MaheshBM, DayJRet al. Vimentin autoantibodies induce platelet activation and formation of platelet–leukocyte conjugates via platelet-activating factor. J. Leukoc. Biol. 83(2), 263–271 (2008).
   PubMed Web of Science ®Google Scholar
• Moisan E , GirardD. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J. Leukoc. Biol.79(3), 489–498 (2006).
   PubMed Web of Science ®Google Scholar
• Nieminen M , HenttinenT, MerinenM, Marttila-IchiharaF, Eriksson Je, Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell. Biol.8(2), 156–162 (2006).
   PubMed Web of Science ®Google Scholar
• Podor TJ , SinghD, ChindemiPet al. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J. Biol. Chem. 277(9), 7529–7539 (2002).
   PubMed Web of Science ®Google Scholar
• Van Beijnum JR , DingsRP, Van Der Linden E et al. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood108(7), 2339–2348 (2006).
   PubMed Web of Science ®Google Scholar
• Xu B , DewaalRM, Mor-VakninN, HibbardC, MarkovitzDM, KahnML. The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol. Cell. Biol.24(20), 9198–9206 (2004).
   PubMed Web of Science ®Google Scholar
• Levin N , BischoffED, DaigeCLet al. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25(1), 135–142 (2005).
   PubMed Web of Science ®Google Scholar
• Liu C , BhattacharjeeG, BoisvertW, DilleyR, EdgingtonT. In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. Am. J. Pathol.163(5), 1859–1871 (2003).
   PubMed Web of Science ®Google Scholar
• Lomonossoff GP , ShanksM. The nucleotide sequence of cowpea mosaic virus B RNA. EMBO J.2(12), 2253–2258 (1983).
   PubMed Web of Science ®Google Scholar
• Chacko AM , HoodED, ZernBJ, MuzykantovVR. Targeted nanocarriers for imaging and therapy of vascular inflammation. Curr. Opin. Colloid Interface Sci.16(3), 215–227 (2011).
   PubMed Web of Science ®Google Scholar
• Lewis DR , KamisogluK, YorkAW, MoghePV. Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.3(4), 400–420 (2011).
   PubMed Web of Science ®Google Scholar
• Douma K , MegensRT, Van Zandvoort MA. Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.3(4), 376–388 (2011).
   PubMed Web of Science ®Google Scholar
• Terashima M , UchidaM, KosugeHet al. Human ferritin cages for imaging vascular macrophages. Biomaterials 32(5), 1430–1437 (2011).
   PubMed Web of Science ®Google Scholar
• Uchida M , KosugeH, TerashimaMet al. Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. ACS Nano 5(4), 2493–2502 (2011).
   PubMed Web of Science ®Google Scholar

Websites

• ImageJ: Image processing and analysis in Java. http://rsbweb.nih.gov/ij/
   Google Scholar
• Imaris (bitplane) software. www.bitplane.com/go/products/imaris
   Google Scholar
• Virus particle explorer. http://viperDB.scripps.edu
   Google Scholar